Skip to main content
ASRAFALL25 Main banner
Icon Legend
Presentation Icons
Ticket Required
Ticket Required

ePosters

(EXP-04) - Exhibit Hall ePosters - Screen 07

Assessing the Role of Masseter Botulinum Toxin Injections in Chronic Migraine: A retrospective single clinic observational study

Friday, November 14, 2025
10:09 AM - 10:17 AM CT
Location: Griffin Hall - Screen 07
Introduction:

Patients with chronic migraines have a high prevalence of myofascial pain which may contribute to migraine attacks. Of these patients, many specify the masseter muscles as sources of myofascial pain. While OnabotulinumtoinA (BoTN/A) injections in the masseters have been studied in myofascial pain in temporomandibular disorders, they have not been studied in migraine.  We aim  to assess the role of masseter BoTN/A in patients with chronic migraine and masseter pain.

    Submitting Author(s)

  • GA

    Gary Allen, MD

    PGY-3 Resident Physician
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

    • Co-Author(s)

  • KG

    Kevin Gilbert, MD

    PGY-3 Resident Physician
    Vanderbilt University Medical Center, United States

  • TK

    Tigran Kesayan, n/a

    Assistant Professor of Anesthesiology and Neurology
    Department of Anesthesiology, Vanderbilt University School of Medicine, United States